What Asia Healthcare Holdings(AHH) does

Asia Healthcare Holdings (AHH) is a single-specialty healthcare operating and investment platform founded in April 2016 by TPG Growth, focused exclusively on building and acquiring branded specialty clinical businesses in India. AHH currently operates three core verticals: Motherhood Hospitals (women and child care, including obstetrics, gynecology, and pediatric services), Nova IVF Fertility (assisted reproduction across 98+ centers), and the Asian Institute of Nephrology and Urology (AINU, a urology and nephrology chain of 7 hospitals with 500+ beds acquired in September 2023 for approximately Rs 600 crore). The platform also operates internal pathology and diagnostics businesses embedded within Motherhood and Nova IVF, with Motherhood diagnostics alone generating Rs 35 crore in revenue. Collectively, AHH runs 150+ hospitals and clinics across 80+ Indian cities, employs 6,100 staff including 2,000 specialist doctors, and is targeting further expansion into Tier-2 and Tier-3 markets as well as adjacent specialties such as gastroenterology.

AHH's business model is patient-pay and insurance-reimbursed specialty clinical care delivered through owned and operated facilities under unified specialty brands. Revenue is generated per clinical episode — deliveries, IVF cycles, urological procedures, dialysis sessions, and ancillary diagnostics — with cross-vertical referral economics, shared back-office, centralized procurement, and a common technology stack creating operating leverage unavailable to standalone operators. The platform has attracted growth capital from GIC, which acquired a 40% stake for approximately $170 million in February 2022, and is currently preparing for a potential public listing within 12-18 months while continuing inorganic expansion (most recently the CRAFT Hospitals acquisition in March 2026 for approximately $40 million).

AHH's stated capital plan calls for $400-500 million of deployment over five years and $150 million over the next two years, financed through a combination of follow-on capital from existing sponsors, operating cash flow, and IPO proceeds. Governance has been upgraded in 2026 with the appointment of Venkatesh Tarakkad as CFO, Ritesh Pandey in a newly created CBO role, and three independent directors. The platform is led by Executive Chairman Vishal Bali and supported by brand-level CEOs across Motherhood, Nova IVF, and AINU.

Name

Asia Healthcare Holdings(AHH)

Legal name

Asia Healthcare Holdings

Website

https://ahholdings.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Asia Healthcare Holdings is a TPG Growth-founded single-specialty healthcare platform operating Motherhood Hospitals, Nova IVF Fertility, and AINU across 150+ facilities and 80+ Indian cities, serving patients in women/maternal care, fertility, and urology/nephrology.

Ownership category

akta.pro rank

Product category

Single-specialty healthcare services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Offices of Physicians, Mental Health Specialists (621112)

SIC

Services-Hospitals (8060), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Hospital-at-Home / Acute Care at Home Programs (HLAFAEAH)

akta.pro secondary industry

Multi-Location & Enterprise Practice Operations (HLACADAG)

Keywords

• Single-specialty healthcare
• Fertility treatment services
• Women and child healthcare
• Urology and nephrology care
• Healthcare investment platform

Headquarters

HQ city

Bengaluru

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Hospital & clinical service revenue: Recurring revenue generated through operating single-specialty hospital chains (Motherhood Hospitals, Nova IVF Fertility, AINU) that bill patients for in-patient, out-patient, surgical, fertility, and diagnostic services across 80+ Indian cities.
2. In-house pathology & diagnostic revenue: Cross-vertical internal pathology services delivered to AHH's own hospitals, currently generating about 400 million rupees (~$4.20M) of pathology work, with planned expansion as a standalone vertical.
3. Healthcare investment platform returns: Capital appreciation and exits from portfolio investments; AHH has invested approximately $200M to date across healthcare enterprises and exited American Oncology Institute (CTSI) to Varian Medical Systems in 2019.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Asia Healthcare Holdings (AHH) is a single-specialty healthcare operating and investment platform that acquires and scales hospital and clinic chains in India across three verticals: women and child care (Motherhood Hospitals), fertility and IVF (Nova IVF Fertility), and urology and nephrology (Asian Institute of Nephrology and Urology / AINU). The platform combines institutional capital (TPG Growth and GIC) with operating expertise to grow more than 150 hospitals and clinics across 80+ Indian cities, employing 6,100 staff and 2,000 doctors. AHH also runs in-house pathology work worth roughly 400 million rupees and is scoping gastroenterology as a future vertical.

Product overview

Asia Healthcare Holdings (AHH) is a single-specialty healthcare operating and investment platform - not a unified software product but a portfolio of independently operated specialty healthcare enterprises. AHH was incubated by TPG Growth in April 2016 and is now backed by TPG Growth and Singapore's sovereign wealth fund GIC. Its current portfolio comprises three core single-specialty enterprises: Motherhood Hospitals (women and child care hospital network), Nova IVF Fertility (fertility treatment chain), and the Asian Institute of Nephrology and Urology / AINU (urology and nephrology chain). AHH previously also owned American Oncology Institute (CTSI), which was exited to Varian Medical Systems in 2019. The platform combines capital, operating expertise, and clinical governance to scale these specialty brands - rather than offering a single unified technology product - and is currently exploring additional verticals such as gastroenterology and pathology diagnostics ahead of a potential IPO.

Differentiator

Problem solved

Functional benefit

Brands

• Motherhood Hospitals: India's fastest-growing single-specialty women & children's hospital network (23 hospitals + 2 clinics, 1000+ gynaecologists/paediatricians/neonatologists).
• Nova IVF Fertility (NIF)
• Asian Institute of Nephrology and Urology (AINU)
• American Oncology Institute

Products and services

• Motherhood Hospitals India's fastest-growing single-specialty women and children's hospital network offering obstetrics, gynaecology, neonatology, pediatric intensive care, and fertility & IVF services. Operates 23 hospitals + 2 clinics with 1,000+ leading gynaecologists, paediatricians and neonatologists, and the largest network of NICUs in India. Targets expectant mothers, neonates, and pediatric patients.
• Nova IVF Fertility Among the largest fertility treatment service providers in India, offering advanced Assisted Reproductive Technology (ART) on par with global standards with standardised and ethical infertility treatment. Operates 98+ fertility centres across 63 cities in India with 120+ doctors and 150+ embryologists; targets couples and individuals seeking fertility treatment, and addresses the need for organized institutional fertility providers.
• Asian Institute of Nephrology and Urology (AINU) India's largest single-specialty hospital network for urology and nephrology care, with pioneering work in robotic urology surgery. Operates 7 hospitals across Hyderabad, Visakhapatnam, Siliguri and Chennai with 500+ beds, 400,000+ patients treated, 50,000+ procedures, 1,000+ robotic urology surgeries, 200,000+ dialysis procedures and 300 kidney transplants. Founded in 2013 by Dr. C. Mallikarjuna and Dr. P. C. Reddy.
• In-house Pathology and Diagnostics Services Cross-vertical internal pathology services delivered to AHH's own hospitals across the Motherhood, Nova IVF, and AINU networks, generating about 400 million rupees of internal work, with planned expansion as a standalone diagnostics vertical.

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• CRAFT Hospitals (Craft Fertility, Kerala)coreStrategic or Co-development Partner · 1 March 2026Nova IVF Fertility acquired a majority stake in Kerala-based CRAFT Hospitals for approximately $40 million (₹368 crore). Craft Fertility has over 55,000 babies born and 30+ years of operating history. The deal was facilitated by investment bank Advay Capital. Nova IVF plans to open 10 new centres in Kerala over 3-5 years.
• Advay CapitalminorImplementation/ SI/ Consulting Partner · 1 March 2026Investment bank Advay Capital advised CRAFT Fertility and its promoter on the sale of a majority stake to Nova IVF Fertility for $40 million (₹368 crore). One-off M&A advisory mandate; not an ongoing alliance.
• Wings (Ahmedabad IVF company)minorStrategic or Co-development Partner · 1 June 2023Nova IVF Fertility (AHH platform) acquired Wings, an Ahmedabad-based IVF company, to expand Nova IVF's presence in Gujarat.
• Chaitanya HospitalcoreStrategic or Co-development Partner · 1 September 2022Motherhood Hospitals (AHH platform) made a strategic investment in Chaitanya Hospital, the leading provider of women and children healthcare services in the Chandigarh Tricity (Chandigarh, Mohali, Panchkula, Zirakpur) for over two decades. The combined entity covers Obstetrics & Gynaecology, Neonatology, Pediatric Intensive Care, Fertility & IVF.
• Femiint Hospitals (Bengaluru)minorStrategic or Co-development Partner · 1 September 2022Motherhood Hospitals (AHH platform) acquired Bengaluru-based Femiint Hospitals as part of its expansion into Karnataka and Bengaluru.
• Southend Fertility & IVFcoreStrategic or Co-development Partner · 1 May 2019Nova IVF Fertility (AHH platform) made a strategic investment in Southend Fertility & IVF, a leading IVF player in Delhi NCR, to expand its presence in the NCR region. The combined entity operates comprehensive fertility centres backed by advanced technology and experienced fertility experts.
• Varian Medical SystemsminorStrategic or Co-development Partner · 1 May 2019AHH divested its American Oncology / Cancer Treatment Services International (CTSI) chain — which had grown to 11 hospitals across South Asia — to Varian Medical Systems in May 2019. No ongoing operating partnership; the relationship is historical.

Scale indicators17 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Manipal Hospitals: One of India's largest multi-specialty hospital chains; overlaps with AHH on women & child, tertiary, and specialty care infrastructure across India. Operates a much broader portfolio of services but competes for the same patient base and clinical talent that AHH's single-specialty brands target.
• Fortis Healthcare: Large Indian hospital chain (and former employer of AHH's Executive Chairman Vishal Bali and Motherhood CEO Vijayrathna Venkatraman). Competes for the same tertiary and specialty patient demand and draws on overlapping clinician pools, making it a direct comparator for hospital-network scale and quality accreditation.
• Apollo Hospitals: India's flagship multi-specialty hospital brand; AHH's CTO previously served as CIO of Apollo. Comparable on hospital-chain operations, technology-led care delivery, and clinical quality benchmarks, and an obvious comparison set for the planned IPO.
• Max Healthcare: Listed North-India multi-specialty hospital network with strong tertiary and quaternary care. Comparable in terms of urban, single-specialty-adjacent service lines (mother & child, urology, IVF) and a relevant IPO/liquidity benchmark for AHH's public-market trajectory.
• CARE Hospitals: Multi-specialty hospital chain in India with strong presence in urology, nephrology and dialysis — directly adjacent to AHH's AINU vertical. Comparable for hospital-network scaling, dialysis-program throughput, and transplant capabilities.

Direct peers

• Cloudnine Hospitals: India's leading single-specialty women, maternity and child-care hospital chain with a comparable NICU- and gynaecology-led model. Direct competitor to Motherhood Hospitals across metros and Tier-1 cities and the closest pure-play comparable for that AHH vertical.
• Rainbow Children's Hospital: Single-specialty paediatric, women and child hospital chain listed in India. Direct competitor to Motherhood in the same NICU-led, paediatric subspecialty category and a key public-market reference for AHH's women & child vertical.
• Indira IVF: Among India's largest fertility/IVF chains by centre count, competing head-to-head with Nova IVF in tier-1 and tier-2 cities. Closest pure-play direct comparable on the fertility vertical that anchors AHH's growth thesis.
• Oasis Fertility: Pan-India fertility chain with ART and embryology services that overlap directly with Nova IVF. Comparable on clinical protocol standardisation, embryologist scale, and tier-2/3 city expansion strategy.

Emerging players

• Karkinos Healthcare: Technology-driven, distributed cancer-care platform in India where AHH's CTO previously served as CIO. Relevant because it operates a tech-enabled specialty model, intersects with AHH's former oncology vertical, and is a candidate counterparty for any future oncology re-entry or partnership.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/asiahealthcareholdings

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries4 records

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Asia Healthcare Holdings(AHH)